We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$143M
2
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$49M
3
CCVI
Churchill Capital Corp VI
CCVI
+$34.2M
4
AMD icon
Advanced Micro Devices
AMD
+$27.5M
5
CLDX icon
Celldex Therapeutics
CLDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPL
226
PUT
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$228K 0.02%
+311,500
New +$3.94M
WFC icon
227
CALL
Wells Fargo
WFC
$265B
$226K 0.02%
50,800
+800
+2% +$42.8K
MAPS
228
DELISTED
WM TECHNOLOGY INC A
MAPS
$223K 0.02%
+28,562
New +$162K
SHEL icon
229
CALL
Shell
SHEL
$250B
$222K 0.02%
+144,400
New +$7.67M
TEVA icon
230
CALL
Teva Pharmaceuticals
TEVA
$42.6B
$214K 0.02%
223,800
– –
VSEEW
231
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$213K 0.02%
+1,261,530
New +$295K
HR icon
232
Healthcare Realty
HR
$6.59B
$211K 0.02%
+6,727
New +$212K
KEY icon
233
KeyCorp
KEY
$24.4B
$210K 0.02%
9,362
-3,061
-25% -$76.1K
VTIQW
234
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$206K 0.02%
457,936
+201,821
+79% +$105K
MRTX
235
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$204K 0.02%
2,483
-3,175
-56% -$325K
PRPC.WS
236
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$198K 0.02%
319,083
+88,736
+39% +$63.6K
GATE
237
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$192K 0.02%
+19,483
New +$191K
ARYD
238
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$192K 0.02%
19,600
-20,400
-51% -$201K
CNDA.WS
239
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$191K 0.02%
319,878
+154,878
+94% +$103K
GNLN icon
240
Greenlane Holdings
GNLN
$1.21M
– –
0
– –
IFF icon
241
CALL
International Flavors & Fragrances
IFF
$21.7B
$188K 0.02%
+15,800
New +$2.1M
CVIIW
242
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$188K 0.02%
312,940
+287,492
+1,130% +$188K
IPOF.WS
243
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$178K 0.02%
+145,044
New +$194K
TGT icon
244
CALL
Target
TGT
$69.1B
$176K 0.02%
19,700
-200
-1% -$43.3K
SRPT icon
245
PUT
Sarepta Therapeutics
SRPT
$1.88B
$170K 0.02%
12,000
+8,300
+224% +$636K
FE icon
246
CALL
FirstEnergy
FE
$27.2B
$160K 0.02%
100,000
-30,900
-24% -$1.31M
JWSM.WS
247
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$160K 0.02%
327,570
+207,760
+173% +$134K
NVACR
248
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$157K 0.02%
+1,116,253
New +$188K
OPA.WS
249
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$150K 0.01%
+156,366
New +$155K
CPARW
250
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$148K 0.01%
267,934
+137,248
+105% +$82.9K
8 9
10
11 12

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.